A Unifying Mechanism for Cancer Cell Death through Ion Channel Activation by HAMLET

Ion channels and ion fluxes control many aspects of tissue homeostasis. During oncogenic transformation, critical ion channel functions may be perturbed but conserved tumor specific ion fluxes remain to be defined. Here we used the tumoricidal protein-lipid complex HAMLET as a probe to identify ion fluxes involved in tumor cell death. We show that HAMLET activates a non-selective cation current, which reached a magnitude of 2.74±0.88 nA within 1.43±0.13 min from HAMLET application. Rapid ion fluxes were essential for HAMLET-induced carcinoma cell death as inhibitors (amiloride, BaCl2), preventing the changes in free cellular Na+ and K+ concentrations also prevented essential steps accompanying carcinoma cell death, including changes in morphology, uptake, global transcription, and MAP kinase activation. Through global transcriptional analysis and phosphorylation arrays, a strong ion flux dependent p38 MAPK response was detected and inhibition of p38 signaling delayed HAMLET-induced death. Healthy, differentiated cells were resistant to HAMLET challenge, which was accompanied by innate immunity rather than p38-activation. The results suggest, for the first time, a unifying mechanism for the initiation of HAMLET’s broad and rapid lethal effect on tumor cells. These findings are particularly significant in view of HAMLET’s documented therapeutic efficacy in human studies and animal models. The results also suggest that HAMLET offers a two-tiered therapeutic approach, killing cancer cells while stimulating an innate immune response in surrounding healthy tissues.

[1]  C. Svanborg.  Conserved features of cancer cells define their sensitivity to HAMLETinduced death; c-Myc and glycolysis , 2013 .

[2]  Aurora Martínez,et al.  HAMLET forms annular oligomers when deposited with phospholipid monolayers. , 2012, Journal of molecular biology.

[3]  J. D. Watson,et al.  Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis , 2011, Oncogene.

[4]  A. Arcangeli.  Ion channels and transporters in cancer. 3. Ion channels in the tumor cell-microenvironment cross talk. , 2011, American journal of physiology. Cell physiology.

[5]  A. Arcangeli,et al.  American Journal of Physiology-Cell Physiology theme: ion channels and transporters in cancer. , 2011, American journal of physiology. Cell physiology.

[6]  N. Prevarskaya,et al.  Calcium in tumour metastasis: new roles for known actors , 2011, Nature Reviews Cancer.

[7]  J. Kukkonen.  A ménage à trois made in heaven: G-protein-coupled receptors, lipids and TRP channels. , 2011, Cell calcium.

[8]  Harald Sontheimer,et al.  Ion channels and transporters [corrected] in cancer. 2. Ion channels and the control of cancer cell migration. , 2011, American journal of physiology. Cell physiology.

[9]  Junying Yuan,et al.  Cell death assays for drug discovery , 2011, Nature Reviews Drug Discovery.

[10]  A. Fontana,et al.  α-Lactalbumin forms with oleic acid a high molecular weight complex displaying cytotoxic activity. , 2010, Biochemistry.

[11]  M. Sokabe,et al.  Mechanosensitivity of ion channels based on protein–lipid interactions , 2010, Journal of The Royal Society Interface.

[12]  L. Pardo,et al.  K(+) channels as therapeutic targets in oncology. , 2010, Future medicinal chemistry.

[13]  C. Svanborg,et al.  HAMLET treatment delays bladder cancer development. , 2010, The Journal of urology.

[14]  G. Hanson,et al.  Cell-Based Potassium Ion Channel Screening Using the FluxOR™ Assay , 2010, Journal of biomolecular screening.

[15]  Ingela Lanekoff,et al.  HAMLET Interacts with Lipid Membranes and Perturbs Their Structure and Integrity , 2010, PloS one.

[16]  J. Schleucher,et al.  Protein oligomerization induced by oleic acid at the solid–liquid interface – equine lysozyme cytotoxic complexes , 2009, The FEBS journal.

[17]  Eric S. Lander,et al.  Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.

[18]  N. Jørgensen,et al.  α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis , 2009, Proceedings of the National Academy of Sciences.

[19]  C. Bortner,et al.  An endogenous calcium-dependent, caspase-independent intranuclear degradation pathway in thymocyte nuclei: antagonism by physiological concentrations of K(+) ions. , 2008, Experimental cell research.

[20]  C. Svanborg,et al.  Bladder cancers respond to intravesical instillation of (HAMLET human α‐lactalbumin made lethal to tumor cells) , 2007, International journal of cancer.

[21]  C. Bortner,et al.  Cell shrinkage and monovalent cation fluxes: role in apoptosis. , 2007, Archives of biochemistry and biophysics.

[22]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[23]  A. Pintzas,et al.  Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects , 2007, Expert opinion on therapeutic targets.

[24]  P. M. Nissom,et al.  A novel normalization method for effective removal of systematic variation in microarray data , 2006, Nucleic acids research.

[25]  Bernd Nilius,et al.  Permeation and selectivity of TRP channels. , 2006, Annual review of physiology.

[26]  Donald E. Ingber,et al.  Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels , 2006, Journal of Cell Science.

[27]  S. Orrenius,et al.  HAMLET triggers apoptosis but tumor cell death is independent of caspases, Bcl-2 and p53 , 2006, Apoptosis.

[28]  Donald E Ingber,et al.  Cell tension, matrix mechanics, and cancer development. , 2005, Cancer cell.

[29]  K. Kunzelmann.  Ion Channels and Cancer , 2005, The Journal of Membrane Biology.

[30]  M. Feldmann,et al.  A Novel Mechanism for TNF-α Regulation by p38 MAPK: Involvement of NF-κB with Implications for Therapy in Rheumatoid Arthritis1 , 2004, The Journal of Immunology.

[31]  C. Svanborg,et al.  Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid. , 2004, The New England journal of medicine.

[32]  Boris Martinac,et al.  Mechanosensitive ion channels: molecules of mechanotransduction , 2004, Journal of Cell Science.

[33]  R. Bjerkvig,et al.  Human α-Lactalbumin Made Lethal to Tumor Cells (HAMLET) Kills Human Glioblastoma Cells in Brain Xenografts by an Apoptosis-Like Mechanism and Prolongs Survival , 2004, Cancer Research.

[34]  H. Kimura,et al.  HAMLET Interacts with Histones and Chromatin in Tumor Cell Nuclei* , 2003, Journal of Biological Chemistry.

[35]  A. Verkhratsky,et al.  Endoplasmic reticulum Ca2+ homeostasis and neuronal death , 2003, Journal of cellular and molecular medicine.

[36]  U. Kaupp,et al.  Cyclic nucleotide-gated ion channels. , 2002, Physiological reviews.

[37]  Warren Strober,et al.  Trypan Blue Exclusion Test of Cell Viability , 2001, Current protocols in immunology.

[38]  S. Pelech,et al.  Stress-induced Inhibition of ERK1 and ERK2 by Direct Interaction with p38 MAP Kinase* , 2001, The Journal of Biological Chemistry.

[39]  S. Linse,et al.  Conversion of alpha-lactalbumin to a protein inducing apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Guggino,et al.  Expression of Cyclic Nucleotide-Gated Cation Channels in Airway Epithelial Cells , 1999, The Journal of Membrane Biology.

[41]  A. Caprioli,et al.  Apoptosis of Renal Cortical Cells in the Hemolytic-Uremic Syndrome: In Vivo and In Vitro Studies , 1998, Infection and Immunity.

[42]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[43]  B. Zhivotovsky,et al.  Apoptosis induced by a human milk protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[44]  F. Duranti,et al.  Intracellular ionic variations in the apoptotic death of L cells by inhibitors of cell cycle progression. , 1995, Experimental cell research.

[45]  E. Permyakov,et al.  Oleic acid is a key cytotoxic component of HAMLET-like complexes , 2012, Biological chemistry.

[46]  C. Hougaard,et al.  Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels. , 2010, American journal of physiology. Cell physiology.

[47]  Jan Lammerding,et al.  Mechanotransduction gone awry , 2009, Nature Reviews Molecular Cell Biology.

[48]  P. Holzer.  Acid-sensitive ion channels and receptors. , 2009, Handbook of experimental pharmacology.

[49]  E. Hoffmann,et al.  Physiology of cell volume regulation in vertebrates. , 2009, Physiological reviews.

[50]  O. Crociani,et al.  Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. , 2009, Current medicinal chemistry.

[51]  C. Svanborg,et al.  Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells). , 2008, Advances in experimental medicine and biology.

[52]  Ashok Kumar,et al.  Regulation of Intracellular Signal Transduction Pathways by Mechanosensitive Ion Channels , 2008 .

[53]  J. A. Peters,et al.  Transient receptor potential cation channels in disease. , 2007, Physiological reviews.

[54]  Michael D. Abràmoff,et al.  Image processing with ImageJ , 2004 .

[55]  R. Bjerkvig,et al.  HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects. , 2003, Advances in cancer research.

[56]  M. Heller.  DNA microarray technology: devices, systems, and applications. , 2002, Annual review of biomedical engineering.

[57]  E. Neher.  Correction for liquid junction potentials in patch clamp experiments. , 1992, Methods in enzymology.

[58]  F. Fitzpatrick,et al.  Inhibition of phospholipase C dependent processes by U-73, 122. , 1989, Advances in prostaglandin, thromboxane, and leukotriene research.